MktsMarkets

Cabaletta Bio, Inc.
NASDAQ: CABAKey statistics
CABA News
Stories mentioning CABA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 37,353 | 36,194 | 39,824 | 37,638 | 29,018 | 25,532 | 26,290 | 23,427 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 44,296 | 42,611 | 46,588 | 45,906 | 37,136 | 33,785 | 33,046 | 30,279 |
| Operating Income (Loss) | (44,296) | (42,611) | (46,588) | (45,906) | (37,136) | (33,785) | (33,046) | (30,279) |
| Interest Income | 1,076 | 1,326 | 1,808 | 1,410 | 1,487 | 1,947 | 2,417 | 2,677 |
| Interest Expense | 636.00 | 555.00 | 584.00 | 571.00 | 294.00 | 748.00 | 0.00 | 0.00 |
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income (Loss) | (43,515) | (41,919) | (44,866) | (45,128) | (35,943) | (32,586) | (30,629) | (27,602) |
| Earnings Per Share (Basic) | (0.39) | (0.22) | (0.44) | (0.73) | (0.71) | (0.65) | (0.62) | (0.56) |
| Earnings Per Share (Diluted) | (0.39) | (0.22) | (0.44) | (0.73) | (0.71) | (0.65) | (0.62) | (0.56) |
| Weighted Average Shares Outstanding (Basic) | 112,025 | 50,743 | ||||||
| Weighted Average Shares Outstanding (Diluted) | 112,025 | 50,743 | ||||||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CABA
Cabaletta Bio, Inc. (NASDAQ: CABA) is a stock listed on the Nasdaq Stock Market under the ticker symbol CABA. It last traded at $1.49 (Nov 9, 2026, 12:39 PM ET), up 14.6% on the day. That gives Cabaletta Bio a market capitalisation of $280.4M.
Over the past 52 weeks CABA has traded between $1.18 and $4.23.
For the quarter ended Mar 31, 2026 it reported a net loss of $43.5M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$43.5M |
| Dec 31, 2025 | — | -$41.9M |
| Sep 30, 2025 | — | -$44.9M |
| Jun 30, 2025 | — | -$45.1M |
From Cabaletta Bio’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…